Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KVB

K V Pharma CL B (KVB)

K V Pharma CL B
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:KVB
DateTimeSourceHeadlineSymbolCompany
06/18/20128:04AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
06/18/20126:08AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
11/16/20117:15PMBusiness WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
11/02/20118:40PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
10/31/20118:30PMBusiness WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
10/28/20113:30PMBusiness WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
10/24/201112:52PMBusiness WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
10/20/20117:47PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
06/13/20117:00AMPR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVBK V Pharma CL B
04/01/20112:08PMDow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVBK V Pharma CL B
04/01/20119:28AMDow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVBK V Pharma CL B
03/31/20114:28PMDow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVBK V Pharma CL B
03/30/20112:58PMDow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
03/30/201111:38AMDow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
03/01/20117:49AMPR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVBK V Pharma CL B
02/14/20119:34AMPR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVBK V Pharma CL B
02/14/20118:48AMPR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVBK V Pharma CL B
02/04/20117:40AMPR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVBK V Pharma CL B
01/12/20118:03AMPR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢NYSE:KVBK V Pharma CL B
09/14/20109:29AMDow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVBK V Pharma CL B
09/10/20108:53AMDow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVBK V Pharma CL B
01/20/20102:41PMDow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVBK V Pharma CL B
01/20/20101:11PMDow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVBK V Pharma CL B
01/11/20108:18AMPR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVB
01/07/20103:10PMPR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVB
12/15/20094:26PMPR Newswire (US)KV Pharmaceutical Sets Record Date for Stockholder Action by Written ConsentNYSE:KVB
12/02/20093:45PMPR Newswire (US)KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van VlietNYSE:KVB
11/13/20093:01PMPR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw AmendmentsNYSE:KVB
10/07/200912:54PMDow Jones NewsLarge Generic Drug Cos Benefiting From Price StabilityNYSE:KVBK-V Pharmaceutical Co. (Cl B)
09/21/20097:30AMPR Newswire (US)KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)NYSE:KVB
 Showing the most relevant articles for your search:NYSE:KVB